PDK1-IN-1 (Compound 2-11) is a PDK1 inhibitor, and can be used for research of myeloproliferative disorders or cancer.
[1]. Jason Katz, et al. Therapeutic compounds. Patent. WO2010017047 A1
[1]. Jason Katz, et al. Therapeutic compounds. Patent. WO2010017047 A1